Introduction
Methylprednisolone 21-acetate is an esterified form of the synthetic glucocorticoid methylprednisolone, designed to enhance stability, prolong duration of action, and improve intramuscular or intra-articular administration. As a potent anti-inflammatory and immunosuppressive agent, it functions by binding to glucocorticoid receptors and modulating transcription of inflammatory mediators, thereby reducing edema, cytokine production, and immune cell activation. Clinically, methylprednisolone 21-acetate is used for acute allergic reactions, autoimmune conditions, joint inflammation, and other corticosteroid-responsive disorders. In research, it serves as a model esterified glucocorticoid for studying steroid metabolism, depot formulations, receptor pharmacology, and analytical method development. Its defined structure and predictable pharmacokinetics make it a widely used reference standard in pharmaceutical testing.